A Case Series of Cabazitaxel Re-Challenge Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer who Have Previously Received Docetaxel and Cabazitaxel Chemotherapy. Issue 2 (February 2020) - Barker, C.L.; Slater, C.; Birtle, A.J.